loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2000_213___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    SAFC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Sigma-Aldrich Corporation Saint Louis US (1)

    filter

    01 Ribonuclease A Type III, Product number R5125 (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Sigma-Aldrich Corporation Saint Lou...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ribonuclease A Type III, Product number R5125

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2000-213 - Rev 02
    Valid
    TSE
    2018-10-04
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-213 - Rev 02 of Sigma-aldrich Corporation Saint Louis Us

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-213 - Rev 02 of Sigma-aldrich Corporation Saint Louis Us 1

    20

    Sigma-aldrich Corporation Saint Louis Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Ribonuclease A Type III, Product number R5125, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-213 - Rev 02

    This TSE Type CEP, issued on October 04, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Post Enquiry
    POST ENQUIRY